Compare APAM & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APAM | HAE |
|---|---|---|
| Founded | 1994 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2011 | 1996 |
| Metric | APAM | HAE |
|---|---|---|
| Price | $37.55 | $59.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $43.00 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 719.9K | 540.5K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 10.81% | N/A |
| EPS Growth | 10.66 | ★ 44.54 |
| EPS | ★ 4.05 | 2.46 |
| Revenue | ★ $1,196,688,000.00 | $910,373,000.00 |
| Revenue This Year | $5.96 | N/A |
| Revenue Next Year | $5.05 | $5.23 |
| P/E Ratio | ★ $9.25 | $24.42 |
| Revenue Growth | ★ 7.63 | N/A |
| 52 Week Low | $34.99 | $47.32 |
| 52 Week High | $48.46 | $87.32 |
| Indicator | APAM | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 49.06 |
| Support Level | $35.01 | $48.47 |
| Resistance Level | $38.75 | $62.78 |
| Average True Range (ATR) | 1.04 | 1.86 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 58.10 | 31.71 |
Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.